IMMUPHARMA AT BIO-EUROPE SPRING 2024. 18-20 March 2024 | Barcelona

14th March 2024 - 11:30 am

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, announces that Tim McCarthy, CEO and Dr Tim Franklin, COO, will be attending BIO-Europe Spring. The event will be held between 18-20 March 2024, in Barcelona.

BIO-Europe Spring is the premier springtime partnering event, designed to provide biotechnology companies with the opportunity to present to and connect with investors together with the global biopharma community.

Commenting on the event, Tim McCarthy, CEO of ImmuPharma said: “Following on from our recent announcements, including moving our lead asset P140 for SLE (Lupuzor™) forward, with our appointed CRO, Simbec-Orion, in parallel with our CIDP program, we are delighted to have BIO-Europe as the next key platform in 2024 to present our unique portfolio to key industry and investment specialists. Our focus will be to secure partnering opportunities across our programs including our P140 platform and our earlier stage but highly exciting anti-infective asset, BioAMB.”

To download announcement click here

Share this article